DSIP
Delta Sleep-Inducing Peptide
Regulatory Status
Included in the broader FDA review set with unresolved safety and efficacy questions.
FDA · Updated Apr 2026
Primarily framed as research-only.
MHRA · Updated Apr 2026
Market treatment remains inconsistent.
TGA · Updated Apr 2026
Not specifically listed in the current WADA notes used here.
WADA · Updated Apr 2026
Overview
DSIP is a sleep-associated peptide with a small and uneven evidence base. It remains more notable for recurring commercial claims than for strong contemporary human data.
Continue Reading
Readers also explore
State of Peptides 2026
Get the free report and peptide profile updates.
Evidence notes, regulatory changes, and practical research guides in your inbox. Education only - not medical advice.
Get the PeptideUnicorn update
New profiles, regulatory changes, practical guides, and vendor review notes delivered to your inbox.
Get our free State of Peptides 2026 report when you subscribe.